We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+18.38%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.71B
AUM Growth
-$281M
Cap. Flow
-$830M
Cap. Flow %
-22.37%
Top 10 Hldgs %
31.98%
Holding
127
New
29
Increased
29
Reduced
22
Closed
37

Top Buys

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$73.3M
2
MCK icon
McKesson
MCK
+$66.4M
3
NOW icon
ServiceNow
NOW
+$60.6M
4
DXC icon
DXC Technology
DXC
+$60M
5
MSFT icon
Microsoft
MSFT
+$58M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$125M
2
MRVL icon
Marvell Technology
MRVL
+$118M
3
BIIB icon
Biogen
BIIB
+$102M
4
WFT
Weatherford International plc
WFT
+$102M
5
CSC
Computer Sciences
CSC
+$98M

Sector Composition

Rank Sector Weight
1 Healthcare 40.08%
2 Technology 13.76%
3 Consumer Discretionary 5.54%
4 Communication Services 4.09%
5 Financials 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KITE
1
DELISTED
Kite Pharma, Inc.
KITE
$181M 4.87%
1,743,351
+897,958
+106% +$73.3M
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$154M 4.15%
2,745,842
+1,053,332
+62% +$42.2M
PBYI icon
3
Puma Biotechnology
PBYI
$428M
$147M 3.96%
1,682,158
+616,802
+58% +$34.5M
XLV icon
4
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$131M 3.52%
+1,647,600
New +$126M
ELV icon
5
Elevance Health
ELV
$84.9B
$104M 2.81%
555,316
+115,190
+26% +$20.7M
BABA icon
6
Alibaba
BABA
$279B
$99.1M 2.67%
703,046
-106,973
-13% -$13.2M
QQQ icon
7
PUT
Invesco QQQ Trust
QQQ
$471B
$98.7M 2.66%
+717,200
New +$98.6M
AERI
8
DELISTED
Aerie Pharmaceuticals
AERI
$91.9M 2.47%
1,748,040
+454,911
+35% +$21.2M
UHS icon
9
Universal Health Services
UHS
$9.05B
$91.1M 2.45%
746,051
+48,093
+7% +$5.72M
GDDY icon
10
GoDaddy
GDDY
$11.9B
$89.4M 2.41%
2,107,643
+328,171
+18% +$13.1M
PCRX icon
11
Pacira BioSciences
PCRX
$1.01B
$87.8M 2.37%
1,840,618
+213,341
+13% +$9.9M
MSFT icon
12
Microsoft
MSFT
$2.89T
$81M 2.18%
1,175,303
+845,099
+256% +$58M
HUM icon
13
Humana
HUM
$48B
$80.9M 2.18%
336,307
-58,535
-15% -$13.3M
EW icon
14
Edwards Lifesciences
EW
$48.6B
$72.7M 1.96%
1,844,433
+474,135
+35% +$17.3M
MCK icon
15
McKesson
MCK
$96.7B
$72.1M 1.94%
+438,055
New +$66.4M
BAX icon
16
Baxter International
BAX
$11.4B
$71.5M 1.93%
1,180,582
+18,094
+2% +$1.03M
MDCO
17
DELISTED
Medicines Co
MDCO
$68.9M 1.86%
1,813,002
-37,633
-2% -$1.68M
NOW icon
18
ServiceNow
NOW
$99.4B
$65.6M 1.77%
+3,093,680
New +$60.6M
BPMC
19
DELISTED
Blueprint Medicines
BPMC
$65.2M 1.76%
1,286,450
+234,438
+22% +$9.95M
CI icon
20
Cigna
CI
$76.7B
$61M 1.64%
364,245
+69,649
+24% +$11.2M
UNH icon
21
UnitedHealth
UNH
$393B
$61M 1.64%
328,829
+15,431
+5% +$2.71M
MOH icon
22
Molina Healthcare
MOH
$11.7B
$60.9M 1.64%
880,402
+346,181
+65% +$21.2M
DXC icon
23
DXC Technology
DXC
$1.52B
$60M 1.62%
+903,852
New +$60M
AMZN icon
24
Amazon
AMZN
$2.62T
$58.5M 1.58%
+1,208,240
New +$57.6M
ABT icon
25
Abbott
ABT
$175B
$53.6M 1.44%
+1,102,781
New +$49.9M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q2 2017 Portfolio in Review

As of Q2 2017, PFM Health Sciences held 127 positions worth $3.71B, down 7% from $3.99B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences withdrew a net $830M in Q2 2017, closing 37 positions and reducing 22 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $125M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 39% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PFM Health Sciences opened a new position in McKesson worth $72.1M.

  • PFM Health Sciences's largest Q2 2017 buy was McKesson: 438,055 shares worth $72.1M.
  • PFM Health Sciences added most to Kite Pharma, Inc. in Q2 2017, an estimated $73.3M increase.
  • PFM Health Sciences's biggest Q2 2017 reduction was Marvell Technology, cutting an estimated $118M.
  • PFM Health Sciences fully exited Jazz Pharmaceuticals in Q2 2017, selling an estimated $125M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.71B portfolio in Q2 2017.
  • PFM Health Sciences opened 29 new positions and closed 37 in Q2 2017.
  • PFM Health Sciences's portfolio value fell 7% quarter-over-quarter to $3.71B.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.